Flu Vaccines
Juvaris BioTherapeutics Announces Award of U01 Cooperative Research Partnership From Niaid
Published in Vaccine Weekly, August 15th, 2007
Juvaris BioTherapeutics, Inc. announced that it has been awarded an estimated $9 million, 5-year grant by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to develop adjuvants for influenza vaccines. This research will be conducted in collaboration with Dr. David Lewis of Stanford University and Dr. Chris Miller of the National Primate Research Center at the University of California, Davis. The results obtained from research carried out under this cooperative partnership will also be applicable to other viral, bacterial and cancer vaccines using the JuvaVax(TM) adjuvant technology currently in development at Juvaris.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-08-15)
More Articles from Vaccine Weekly
- Dentistry
Is G8 putting profits before the world's poorest children? - HIV/AIDS
New target for HIV/AIDS drugs and vaccine discovered - HIV/AIDS Co-Infection
Trials underway for 'essential' new TB vaccine - Cancer Vaccines
CDC Urges Parents to Protect Preteens With Three Recommended Vaccines - Cancer Vaccines
D.C. Denies Prostate Cancer Vaccine, Provenge: Dendreon (WA) Not FDA To Blame - Cancer Vaccines
HPV Vaccine a Matter of Individual Choice, Not Government Mandate, Says Harvard Women's Health Watch - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
